Massachusetts Financial Services
GHDX

Massachusetts Financial Services’s Genomic Health, Inc. GHDX Stock Holding History

Massachusetts Financial Services’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,582
Closed -$615K – 871
2019
Q2 		$615K Buy
10,582
+1,474
+16% +$87.3K ﹤0.01% 807
2019
Q1 		$638K Buy
9,108
+336
+4% +$24.9K ﹤0.01% 802
2018
Q4 		$565K Sell
8,772
-7,927
-47% -$556K ﹤0.01% 805
2018
Q3 		$1.17M Sell
16,699
-39
-0.2% -$2.28K ﹤0.01% 778
2018
Q2 		$844K Buy
16,738
+2,291
+16% +$90.9K ﹤0.01% 789
2018
Q1 		$452K Buy
+14,447
New +$479K ﹤0.01% 808

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Massachusetts Financial Services's GHDX Position: Q3 2019 in Review

Massachusetts Financial Services sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 10,582 shares — an estimated $615K sold.

Massachusetts Financial Services first reported a position in GHDX in Q1 2018 and held it in 6 quarters. The position peaked at $1.17M in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Massachusetts Financial Services reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Massachusetts Financial Services sold 10,582 Genomic Health, Inc. shares in Q3 2019, an estimated $615K.
  • Massachusetts Financial Services first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 6 quarters.
  • Massachusetts Financial Services's Genomic Health, Inc. position peaked at $1.17M in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Massachusetts Financial Services's 13F filing for Q3 2019, filed 5 Nov 2019.